MA-DESKTOP-METAL
19.4.2022 14:32:12 CEST | Business Wire | Press release
Desktop Metal (NYSE: DM) today announced the launch of the ExOne S-Max® Flex, a scalable, large-format binder jetting system that 3D prints sand tooling, which foundries use to quickly cast complex metal designs for the aerospace, automotive, and energy industries, among others.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220419005064/en/
ExOne, which was acquired by Desktop Metal in late 2021, is the leading digital sand printing solution provider for foundries. The new S-Max Flex combines ExOne’s sand printing expertise in process and materials with proprietary Desktop Metal SPJ technology in an affordable architecture to deliver new value to foundries that have long wanted an S-Max but found the premium price out of reach.
The S-Max Flex will debut at CastExpo 2022, North America’s largest metalcasting trade show, from April 23-26 in Columbus, Ohio. A video highlighting the benefits of the S-Max Flex for early customers, including Alpha Foundry of Wright City, Mo., and D.W. Clark in Taunton, Mass., was released today at www.exone.com/flexvideo .
“To achieve our vision of Additive Manufacturing 2.0, we need to make production 3D printing practical in terms of speed, cost, and material availability for a broad range of applications,” said Ric Fulop, Co-Founder and CEO of Desktop Metal. “We designed the all-new S-Max Flex from the ground up leveraging SPJ technology with the idea of making premium sand 3D printing accessible to every foundry, so that more companies can take advantage of the benefits of AM 2.0, such as distributed, local production, and remain competitive for the long term.”
The S-Max Flex comes to market at a time of strong demand for castings, along with challenges finding labor. After years of contraction, the U.S. metalcasting industry is experiencing growth as a result of supply chain changes related to the COVID-19 pandemic. A recent survey released by the American Foundry Society shows that 90 percent of responding North American foundries have a positive business outlook and anticipate making capital investments in the next 12 months, including of 3D printers.
Additional early buyers of the new S-Max Flex include Founders Service & Manufacturing Co. Inc. of Deerfield, Ohio, and HTCI Co. of New Carlisle, Ohio.
Details of the S-Max Flex
The S-Max Flex pairs an affordable industrial robot with an all-new end effector printhead design that deposits binder into a 1900 x 1000 x 1000 mm (74 x 39 x 39 in) telescoping build box that grows as the parts are built layer by layer. Additional build box sizes are available up to 4700 x 1000 x 1000 mm (185 x 39 x 39 in), with taller versions available up to 1000 x 2500 x 2400 mm (39 x 98 x 94 in).
Desktop Metal’s high throughput SPJ technology delivers a build rate up to 115 l/h, which offers foundries quick and reliable production to operate more efficiently in times of ongoing labor shortages, as well as a faster return on investment. The S-Max Flex joins the premium S-Max® and S-Max® Pro solutions that are used in foundries worldwide.
The all-new S-Max Flex prints standard silica sand with furan binders and delivers final parts with dimensional accuracy of +/- 0.5 mm. The system comes with several accessories and safety features that are configurable to fit a variety of spaces.
Industries beyond metalcasting are also set to take advantage of the S-Max Flex’s large form factor and ability to binder jet a variety of powders. Infiltrated sand tooling for plastic thermoforming, composite layup, and sacrificial tooling applications are printed today on S-Max machines, along with infiltrated sand consumer products, such as those offered by Sandhelden and Deeptime . Desktop Metal’s Forust brand, which upcycles byproducts of the wood waste stream into consumer designs, will also leverage the new system to print large form factor wood parts at scale cost-effectively. Additional projects are underway printing reclaimed concrete and other materials.
Binder Jetting - the Fastest AM Method for Mass Production
Binder jet 3D printing is widely regarded as the fastest additive manufacturing method for the mass production of functional precision parts. Sand binder jet 3D printing has been used in foundries for more than two decades to create metalcasting tooling cost-effectively and with low turnaround times.
In the binder jetting process, an industrial printhead selectively deposits a binder into a bed of sand particles creating a solid part one thin layer at a time, similar to printing on sheets of paper. 3D printing straight from CAD files enables foundries to eliminate the months-long lead times and high costs of traditional patterns and coreboxes created from wood or metal. The design freedom of additive manufacturing also allows designers to innovate the parts made with the reliable casting process – creating complex, consolidated geometries that enable lightweighting and optimized part performance not possible with traditional processes.
For more information on the ExOne S-Max Flex system, visit www.exone.com .
About Desktop Metal
Desktop Metal, Inc., based in Burlington, Massachusetts, is accelerating the transformation of manufacturing with an expansive portfolio of 3D printing solutions, from rapid prototyping to mass production. Founded in 2015 by leaders in advanced manufacturing, metallurgy, and robotics, the company is addressing the unmet challenges of speed, cost, and quality to make additive manufacturing an essential tool for engineers and manufacturers around the world. Desktop Metal was selected as one of the world’s 30 most promising Technology Pioneers by the World Economic Forum, named to MIT Technology Review’s list of 50 Smartest Companies, and the 2021 winner of Fast Company’s Innovation by Design Award in materials and Fast Company’s Next Big Things in Tech Award for sustainability. For more information, visit www.desktopmetal.com
.
Forward-looking Statements
This press release contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks, uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to, the risks and uncertainties set forth in Desktop Metal, Inc.'s filings with the U.S. Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Desktop Metal, Inc. assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220419005064/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 12:00:00 CEST | Press release
TEVIMBRA plus ZIIHERA and chemotherapy regimen delivered statistically significant median OS of 26.4 months, an unprecedented result in this challenging diseaseResults from the global Phase 3 HERIZON-GEA-01 study demonstrate potential to change clinical practice in advanced HER2+ gastroesophageal adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indica
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 11:30:00 CEST | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt
Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 10:27:00 CEST | Press release
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,
The Jury Has Been Announced for the Third Edition of the Reply AI Film Festival, Dedicated to the Best Short Films Generated With Artificial Intelligence29.4.2026 10:00:00 CEST | Press release
Gabriele Salvatores, together with Rob Minkoff, Catherine Hardwicke, Jed Weintrob, Christina Lee Storm, Nils Hartmann, Guillem Martinez Roura, Filippo Rizzante, Giacomo Mineo, Brian Welk and Denise Negri, will judge the short films in competition based on creativity, production quality and the use of Artificial Intelligence. Reply [EXM, STAR: REY], an international group specialized in creating new business models enabled by AI and long committed to guiding younger generations in exploring emerging technologies, presents the jury of the third edition of the Reply AI Film Festival, the international competition aimed at creatives, directors, and filmmakers who want to challenge themselves in producing short films created using Artificial Intelligence tools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429288361/en/ “Imaginatio Nova” is the theme of the 2026 edition, an invitation to explore a new phase of imagination, wh
Bregal Milestone Announces Majority Growth Investment in CoreGo, a Leading European Open-Loop Payment and Event Technology Company29.4.2026 10:00:00 CEST | Press release
Investment follows over 98% annual growth and supports CoreGo’s continued market expansion Bregal Milestone, a leading European software growth private equity firm, today announced a majority strategic growth investment in CoreGo Oy ("CoreGo" or the "Company"), a leading provider of open-loop payments and integrated technology solutions for festivals, sports events, and venues across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427991105/en/ Founded in Helsinki in 2015 by Hannu Elomaa and CTO Nikoteemu Väänänen, CoreGo has built one of Europe's most differentiated open-loop payment infrastructure and event technology businesses. Serving approximately 250 customers across the Nordics and DACH region, the Company delivers an integrated showtime-critical suite of solutions through CoreGo Cloud, unifying payments, access, networks, and data into a single real-time operating system. CoreGo’s in-house private network
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
